ArticleTurkish journal of obstetrics and gynecology2015

The combination of dehydroepiandrosterone, transdermal testosterone, and growth hormone as an adjuvant therapy in assisted reproductive technology cycles in patients aged below 40 years with diminished ovarian reserve.

Bülent Haydardedeoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.